Pulmonx Corporation Interest Expense 2011-2026 | LUNG

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense Pulmonx Corporation

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
256 K	-673 K	1.07 M	829 K	3.18 M	2.32 M	2.52 M	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
3.18 M	-673 K	1.36 M

Quarterly Interest Expense Pulmonx Corporation

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
758 K	-116 K	167 K	-	-201 K	-35 K	415 K	-	-262 K	-162 K	571 K	-	286 K	223 K	198 K	-	207 K	206 K	217 K	-	1.1 M	912 K	899 K	-	460 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
1.1 M	-262 K	308 K

Interest Expense of other stocks in the Medical devices industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
AxoGen AXGN	-199 K	$ 31.65	-5.55 %	$ 1.4 B	USA
Abiomed ABMD	58.7 M	-	-	$ 17.2 B	USA
Cognyte Software Ltd. CGNT	-1.61 M	$ 9.76	1.99 %	$ 701 M	Israel
Acutus Medical AFIB	5.66 M	-	-26.83 %	$ 2.62 M	USA
Allied Healthcare Products AHPI	191 K	-	3.58 %	$ 2.21 M	USA
Apollo Endosurgery APEN	4.67 M	-	-	$ 475 M	USA
Apyx Medical Corporation APYX	2.48 M	$ 3.92	12.33 %	$ 136 M	USA
Alphatec Holdings ATEC	24.9 M	$ 17.97	-20.68 %	$ 2.57 B	USA
Axonics Modulation Technologies AXNX	-2.43 M	-	-	$ 3.31 B	USA
Bio-Rad Laboratories BIO	48.9 M	$ 322.91	-0.16 %	$ 9.11 B	USA
Bruker Corporation BRKR	-38.2 M	$ 53.33	-2.07 %	$ 7.95 K	USA
BioSig Technologies BSGM	23 K	-	37.08 %	$ 85.7 M	USA
Boston Scientific Corporation BSX	305 M	$ 95.53	-2.13 %	$ 141 B	USA
EDAP TMS S.A. EDAP	232 K	$ 4.1	11.41 %	$ 153 M	France
Abbott Laboratories ABT	376 M	$ 124.29	-1.27 %	$ 216 B	USA
Conformis CFMS	2.02 M	-	-	$ 16.4 M	USA
CONMED Corporation CNMD	37.3 M	$ 43.45	1.31 %	$ 1.34 B	USA
Cardiovascular Systems CSII	1.63 M	-	0.15 %	$ 844 M	USA
Cutera CUTR	-244 K	-	-10.19 %	$ 1.99 M	USA
Neovasc NVCN	133 K	-	-	$ 111 M	Canada
Integra LifeSciences Holdings Corporation IART	3.94 M	$ 13.09	-3.61 %	$ 1.01 B	USA
Dynatronics Corporation DYNT	410 K	-	14.99 %	$ 929 K	USA
Eargo EAR	549 K	-	-	$ 10.2 M	USA
Electromed ELMD	78 K	$ 28.66	-0.49 %	$ 242 M	USA
Second Sight Medical Products EYES	1.19 M	-	-0.97 %	$ 54.4 M	USA
Align Technology ALGN	7.68 M	$ 171.78	-0.58 %	$ 12.9 B	USA
Accuray Incorporated ARAY	13 M	$ 0.88	-0.46 %	$ 90.4 M	USA
IRadimed Corporation IRMD	164 K	$ 97.57	-1.39 %	$ 1.24 B	USA
OrthoPediatrics Corp. KIDS	-1.07 M	$ 20.12	9.89 %	$ 464 M	USA
Avinger AVGR	1.72 M	-	-20.74 %	$ 369 K	USA
ClearPoint Neuro CLPT	-40 K	$ 15.66	4.96 %	$ 423 M	USA
FONAR Corporation FONR	347 K	$ 18.6	0.27 %	$ 122 M	USA
Globus Medical GMED	2.2 M	$ 91.33	-3.28 %	$ 12.4 B	USA
Aziyo Biologics AZYO	5.8 M	-	1.37 %	$ 20.5 M	USA
Myomo MYO	21.1 K	$ 0.99	0.29 %	$ 6.98 M	USA
Establishment Labs Holdings ESTA	-15.3 M	$ 66.18	-3.17 %	$ 1.86 B	Costa-rica